 | FRI, OCT 23, 2020 | | | | Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.
At the presidential debate last night, former Vice President Joe Biden warned that the U.S. was heading for a "dark winter" as Covid-19 cases in the U.S. and Europe continue rise heading into flu season. The U.S. reported 71,600 new cases yesterday, the highest total since late July. Hospitalizations are also growing. We have more on the outbreak below. CNBC's Chrissy Farr also reports on controversial "human challenge studies" in the UK.
| | FDA approves first drug for Covid-19: Gilead's remdesivir | The FDA approved Gilead Sciences' antiviral drug remdesivir as a treatment for the coronavirus. The intravenous drug, under the brand name Veklury, is now the first and only FDA approved drug for Covid-19. The drug will be used for patients at least 12 years of age who require hospitalization, the company said. It has helped shorten the recovery time of some hospitalized Covid-19 patients, and it was one of the drugs used to treat President Donald Trump, who tested positive for the virus earlier this month. The drug hasn't been shown to lower mortality, however. A study coordinated by the WHO had indicated that the drug had "little or no effect" on death rates among hospitalized patients.
-Berkeley Lovelace Jr. | | | | FDA begins the Covid-19 vaccine review process | The agency didn't actually have a specific vaccine yet to discuss, but it held a 9-hour long meeting this week for its outside panel of advisors to talk about the path for Covid-19 vaccines to market. Some of the things we learned: early recipients of vaccines could be getting daily text messages from CDC to track any side effects, and we all might be given "vaccine cards" when we get our shots, to make sure we get the right one a few weeks later for the necessary second dose. This as we're just days away, potentially, from the first phase three trial data, from Pfizer and BioNTech.
-Meg Tirrell | | | | UK moves a step forward with controversial 'human challenge studies' | Healthy, young people in the UK may soon be asked to get deliberately exposed to the coronavirus as part of a set of so-called "human challenge studies." The idea behind these studies is to speed up the process of developing a new vaccine by inoculating volunteers and then deliberately exposing them to the virus to measure if the vaccine works. For the first step, approved this week, the government has signed a contract with a pharmaceutical services company called Open Orphan for a "characterization study," which involves identifying the most appropriate dose of the virus for use in future human challenge studies
-Chrissy Farr | | | | Physicians warn vaccine may not prevent Covid from becoming endemic | The development of a Covid-19 vaccine may not be enough to prevent the coronavirus from becoming endemic, infectious disease experts warn, suggesting a better way for people to proceed would be to learn to live with the virus. Many governments have sought to help the Covid-19 vaccine race by providing funds to allow companies to scale up manufacturing even before drugs have been approved. Dr. David Heymann, who led the WHO's infectious disease unit during the SARS epidemic, believes some governments may be over-reliant on the development of a vaccine at a time when effective communication, diagnostic testing and outbreak containment activities are all critically important tools. "We have to learn to live with the pandemic," he said.
-Sam Meredith | | | | A majority of U.S. states qualify for New York's Covid travel restriction | In what Gov. Andrew Cuomo called a "bizarre outcome," people traveling to New York from 43 states and territories now meet the criteria to quarantine for two weeks upon arrival or face fines. The Covid-19 outbreaks sweeping the nation ahead of the holiday season have grown so severe that even neighboring Connecticut, Pennsylvania and New Jersey are reporting spikes that would land them on the list. However, Cuomo said "is not practically viable" to quarantine travelers from those states given that residents frequently travel between them. "The norm in the country is going up. We are not going up the way the norm in the country is going up and hence they're quote unquote quarantined from New York," he said.
-Noah Higgins-Dunn | | CNBC Evolve Summit | November 10, 2020
In an era of rapid technological advances and demographic change, how do legacy companies adapt, innovate and evolve?
CNBC Evolve features iconic global companies and executives who are embracing change and transforming for the future.
Featuring best-in class CEOs and innovators in conversation with CNBC anchors and reporters, this event provides a forum for companies to share strategies, tactics and lessons learned in a peer-to-peer environment.
Attendees will walk away with an understanding of how businesses and brands can evolve and win in an age of disruption.
Featured speakers include:
Al Kelly, Visa
Lisa Safarian, Bayer North America
Arvind Krishna, IBM
Tom Hayes, Ocean Spray
Kelly Caruso, Shipt
Stan Kasten, Los Angeles Dodgers
Lisa Deverell, Land O'Lakes
Darius Adamczyk, Honeywell
| |
Tidak ada komentar:
Posting Komentar